The Full-Year Continuing Appropriations and Extensions Act of 2025 provides $650 million in funding for the Congressionally Directed Medical Research Programs (The Cancer Letter, March 28, 2025). Congress provided further guidance for CDMRP program-level funding, including funding for the Rare Cancers Research Program.
On April 21, investigators with the Women’s Health Initiative were notified that HHS planned to terminate the WHI Regional Center contracts at the end of the current fiscal year (The Cancer Letter, April 20, 2025).
